 "Firms selling anti-TB medicines are now shifting focus to govt tender biz")
Soon, India’s fight against tuberculosis (TB) is likely to have another weapon in its arsenal – an adult TB vaccine.
According to government sources, a recombinant Bacille Calmette–Guérin (rBCG) vaccine may soon be available for adults in India, thanks to Pune-based Serum Institute of India’s (SII’s) tireless efforts.
“SII is working on the rBCG vaccine. The Phase 3 clinical trials on adults are on. The data may be unblended soon,” said a senior government official in the know. He added that the rBCG vaccine for adults may be available within a year or so.
SII did not comment on the
